Search
for
Sort by
Research 31–60 of 1000+
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Hirsutism and virilization
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- Case 33-2015
- Supraphysiological Dose of Testosterone Impairs the Expression and Distribution of Sex Steroid Receptors during Endometrial Receptivity Development in Female Sprague–Dawley Rats
- Steroidogenesis in steroid related cancers
- KRT17 promotes endometrial cancer cell migration as well as angiogenesis by regulating HIF-1α/VEGF pathway
- Immunohistochemical Analysis of the Mechanistic Target of Rapamycin and Hypoxia Signalling Pathways in Basal Cell Carcinoma and Trichoepithelioma
- Cutaneous Neoplasms in Myotonic Dystrophy Type 1
- Causal Relationship and Potential Common Pathogenic Mechanisms Between Alopecia Areata and Related Cancer
- INTERFERONS IN DERMATOLOGY
- MmuPV1-Induced Cutaneous Squamous Cell Carcinoma Arises Preferentially from Lgr5+ Epithelial Progenitor Cells
- S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma
- Somatic Mutations in Normal Tissues: New Perspectives on Early Carcinogenesis
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
- Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
- A benign cause of hyperandrogenism in a postmenopausal woman
- Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- Reproduction of the human relevant potency threshold (HRPT) for estrogen receptor alpha agonism in an inference performance screen for ICCVAM’s regulatory scientific confidence framework
- Abstracts from the 2024 WDS Forum - virtual option
- Cellular heterogeneity and microenvironmental control of skin cancer
- Targeting of Smoothened for therapeutic gain
- Acute sensitivity of the oral mucosa to oncogenic <i>K‐ras</i>
- Acquired hypertrichosis lanuginosa: Case report and review of the literature